These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851 [TBL] [Abstract][Full Text] [Related]
3. Oncogene-induced senescence as an initial barrier in lymphoma development. Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837 [TBL] [Abstract][Full Text] [Related]
4. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310 [TBL] [Abstract][Full Text] [Related]
5. Tumour biology: senescence in premalignant tumours. Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833 [TBL] [Abstract][Full Text] [Related]
6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530 [TBL] [Abstract][Full Text] [Related]
8. Genetic interactions between Pten and p53 in radiation-induced lymphoma development. Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978 [TBL] [Abstract][Full Text] [Related]
10. PTEN and p53: who will get the upper hand? Trotman LC; Pandolfi PP Cancer Cell; 2003 Feb; 3(2):97-9. PubMed ID: 12620402 [No Abstract] [Full Text] [Related]
11. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene. Tolkacheva T; Chan AM Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513 [TBL] [Abstract][Full Text] [Related]
12. [Expression of PTEN, p16, p21, and p53 proteins in lung cancer using tissue microarray and their clinical significance]. Liao XB; Hu DX; Zhou XM; Yu FL; Yuan YC; Chen MJ Ai Zheng; 2004 Mar; 23(3):334-8. PubMed ID: 15025970 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635 [TBL] [Abstract][Full Text] [Related]
20. The regulation of INK4/ARF in cancer and aging. Kim WY; Sharpless NE Cell; 2006 Oct; 127(2):265-75. PubMed ID: 17055429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]